Target intelligence / Profile preview

RNA sensing pathways

Molecular classification
Pattern recognition receptor, Toll-like receptor, RIG-I-like receptor, Signal transducer
01

Overview

RNA sensing pathways are essential components of the innate immune system that detect foreign or misplaced ribonucleic acids to initiate protective responses. These pathways primarily utilize two classes of pattern recognition receptors (PRRs): the endosomal Toll-like receptors (TLR3, TLR7, and TLR8) and the cytosolic RIG-I-like receptors (RIG-I and MDA5) (Chow et al., 2018, Nature Reviews Immunology). Upon binding to specific RNA ligands—such as double-stranded RNA or 5-triphosphorylated single-stranded RNA—these receptors trigger signaling cascades through adapter proteins like TRIF or MAVS, leading to the activation of IRF3/7 and NF-κB (Schlee and Hartmann, 2016, Nature Reviews Immunology). This activation results in the robust production of type I interferons and pro-inflammatory cytokines, which establish an antiviral state and bridge innate and adaptive immunity. In clinical development, agonists of these pathways are being investigated as vaccine adjuvants and cancer immunotherapies to stimulate immune surveillance, while antagonists are being explored for autoimmune diseases like systemic lupus erythematosus, where aberrant sensing of self-RNA drives chronic inflammation (Wu and Chen, 2014, Annual Review of Immunology).

Other names
Innate RNA sensingNucleic acid sensing pathwaysTLR/RLR signaling pathwaysViral RNA sensing
02

Mechanism of action

Agonism of pattern recognition receptors (TLRs and RLRs) to induce type I interferons and pro-inflammatory cytokines for antiviral or antineoplastic effects; Antagonism of these receptors or inhibition of endosomal acidification to suppress pathological autoimmune signaling.

03

Biological functions

Immune responseSignal transductionAntiviral responseApoptosisCytokine production
04

Disease associations

InfectionCancerAutoimmune diseaseInflammationSystemic lupus erythematosus
05

Safety considerations

Cytokine release syndromeSystemic inflammatory responseInduction of autoimmunityFlu-like symptomsInjection site reactions
06

Interacting drugs

Imiquimod

7 more in the full profile.

07

Biomarkers

Interferon-alpha (IFN-α)Interferon-beta (IFN-β)CXCL10 (IP-10)Interferon-stimulated genes (ISGs)ISG15MX1

Beyond the preview

Go deeper on RNA sensing pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA sensing pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call